Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.6K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.6K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

2.9K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.9K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

8.7K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
8.7K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

773
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
773
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

573
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
573

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between pre-existing cardiovascular disease and cancer treatment receipt in a population-based cancer registry.

Scientific reports·2026
Same author

Impact of a sleep practitioner clinic on melatonin de-prescribing in children with neurodevelopmental conditions: A pilot study.

Sleep medicine·2025
Same author

Percutaneous mechanical circulatory support for acute right heart failure: A practical approach.

ESC heart failure·2025
Same author

Medical professionalism education: a systematic review of interventions, outcomes, and sustainability.

Frontiers in medicine·2025
Same author

"Busting the hidden curriculum" a realist and innovative perspective to foster professional behaviors.

Frontiers in medicine·2024
Same author

Baseline Cardiac Parameters as Biomarkers of Radiation Cardiotoxicity in Lung Cancer: An NI-HEART Analysis.

JACC. CardioOncology·2024

Related Experiment Video

Updated: Apr 15, 2026

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

19.1K

Endothelial Function in Hypertension: Victim or Culprit?

Caroline Bleakley1, Paul Kevin Hamilton1, Richard Pumb1

  • 1Department of Cardiovascular Therapeutics & Pharmacology, Queen's University Belfast, Belfast, UK.

Journal of Clinical Hypertension (Greenwich, Conn.)
|April 11, 2015
PubMed
Summary

The endothelium regulates vascular tone via nitric oxide (NO). Dysfunction, marked by NO depletion and oxidative stress, contributes to cardiovascular disease and microvascular changes, highlighting it as a key intervention target.

More Related Videos

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

28.2K
Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
08:41

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Published on: June 3, 2019

10.5K

Related Experiment Videos

Last Updated: Apr 15, 2026

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

19.1K
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

28.2K
Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
08:41

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Published on: June 3, 2019

10.5K

Area of Science:

  • Cardiovascular Science
  • Vascular Biology
  • Endothelial Function

Background:

  • The endothelium, a cellular monolayer lining blood vessels, actively regulates vascular tone.
  • In cardiovascular disease, risk factors initiate atherosclerosis at the endothelial level.
  • Endothelial dysfunction is a predictor of future cardiovascular health.

Purpose of the Study:

  • To elucidate the role of the endothelium in maintaining vascular tone.
  • To understand the mechanisms of endothelial dysfunction in cardiovascular disease.
  • To highlight microvascular dysfunction as a target for cardiovascular event prevention.

Main Methods:

  • Analysis of endothelial mediators, including nitric oxide (NO) and superoxide.
  • Assessment of endothelial NO synthase (eNOS) activity and nicotinamide adenine dinucleotide oxidase.
  • Evaluation of microvascular structural changes and their relation to macrovascular events.

Main Results:

  • Healthy vasculature exhibits abundant NO, promoting vasodilation, anti-inflammation, and anti-platelet aggregation.
  • Endothelial dysfunction involves reduced NO bioavailability due to decreased eNOS activity and increased reactive oxygen species.
  • Impaired vascular compliance and microvascular dysfunction are linked to vasoconstriction and predict macrovascular events.

Conclusions:

  • Endothelial dysfunction, characterized by NO depletion and oxidative stress, is central to cardiovascular disease initiation.
  • Microvascular dysfunction is an early, critical event in endothelial dysfunction and a strong predictor of cardiovascular events.
  • Targeting microvascular dysfunction in hypertensive populations offers a promising strategy for cardiovascular event prevention.